Insulin gel as an alternate to parenteral insulin: formulation, preclinical, and clinical studies
- PMID: 16353976
- PMCID: PMC2750530
- DOI: 10.1208/pt060227
Insulin gel as an alternate to parenteral insulin: formulation, preclinical, and clinical studies
Abstract
The objective of the present study was to formulate insulin gel for intranasal administration and to evaluate with respect to in vitro release studies and hypoglycemic activity in animal model and healthy human volunteers. The insulin gel was formulated using the combination of carbopol and hydroxypropyl methylcellulose as gelling agent. The in vivo efficacy of insulin gel administered intranasally was assessed by measuring the blood glucose levels and serum insulin levels at specified time intervals in rats and humans. The use of bioadhesive nasal gel containing insulin not only promoted the prolonged contact between the drug and the absorptive sites in the nasal cavity but also facilitated direct absorption of medicament through the nasal mucosa. Absorption of the drug through the nasal mucosa was high in the first 0.5 to 1.5 hours of the study with a sharp decline in blood sugar and rise in insulin values corresponding to that decline in blood sugar. This study further demonstrates that administration of insulin intranasally in gel form is a pleasant and painless alternative to injectable insulin.
Similar articles
-
Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies.Int J Pharm. 2004 Aug 20;281(1-2):11-23. doi: 10.1016/j.ijpharm.2004.05.007. Int J Pharm. 2004. PMID: 15288339
-
Design and development of insulin emulgel formulation for transdermal drug delivery and its evaluation.Pak J Pharm Sci. 2013 Mar;26(2):323-32. Pak J Pharm Sci. 2013. PMID: 23455203
-
Nasal delivery of insulin using bioadhesive chitosan gels.Drug Deliv. 2006 Jan-Feb;13(1):31-8. doi: 10.1080/10717540500309040. Drug Deliv. 2006. PMID: 16401591
-
Inhaled insulin-intrapulmonary, intranasal, and other routes of administration: mechanisms of action.Nutrition. 2010 Jan;26(1):33-9. doi: 10.1016/j.nut.2009.08.001. Nutrition. 2010. PMID: 20005465 Review.
-
Intranasal administration of insulin to humans.Diabetes Res Clin Pract. 1991 May;12(2):71-84. doi: 10.1016/0168-8227(91)90083-p. Diabetes Res Clin Pract. 1991. PMID: 1879306 Review.
Cited by
-
Carbopol-based gels for nasal delivery of progesterone.AAPS PharmSciTech. 2008;9(4):1078-82. doi: 10.1208/s12249-008-9144-7. Epub 2008 Oct 11. AAPS PharmSciTech. 2008. PMID: 18850277 Free PMC article.
-
Hydroxyethylcellulose-Based Hydrogels Containing Liposomes Functionalized with Cell-Penetrating Peptides for Nasal Delivery of Insulin in the Treatment of Diabetes.Pharmaceutics. 2022 Nov 17;14(11):2492. doi: 10.3390/pharmaceutics14112492. Pharmaceutics. 2022. PMID: 36432681 Free PMC article.
-
Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the art.Expert Opin Drug Deliv. 2013 Dec;10(12):1699-709. doi: 10.1517/17425247.2013.856877. Epub 2013 Nov 12. Expert Opin Drug Deliv. 2013. PMID: 24215447 Free PMC article. Review.
-
Thermoreversible-mucoadhesive gel for nasal delivery of sumatriptan.AAPS PharmSciTech. 2006 Aug 4;7(3):67. doi: 10.1208/pt070367. AAPS PharmSciTech. 2006. PMID: 17025248 Free PMC article.
-
Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents.J Clin Invest. 2010 May;120(5):1774-85. doi: 10.1172/JCI41356. Epub 2010 Apr 19. J Clin Invest. 2010. PMID: 20407211 Free PMC article.
References
-
- Davis SN, Granner DK. Insulin, oral hypoglycemic agents, and the pharmacotherapy of the endocrine pancreas. In: Hardman JG, Limbird LE, editors. The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill; 1996. pp. 1487–1517.
-
- Arunachalam S, Gunasekaran S. Diabetic research in India, and China today: from literature-based mapping to health-care policy. Curr Sci. 2002;9–10:1086–1097.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical